Dr Tracey Batten appointed as independent director
14 June 2021
NZX/ASX Code: EBO
Dr Tracey Batten appointed as independent director
EBOS Group Limited (EBOS) is pleased to advise of the appointment of Dr Tracey Batten as an
independent director, effective 1 July 2021.
Dr Batten brings to the EBOS Board a wealth of healthcare sector experience gained in both non-
executive and senior executive roles, as well as medical practitioner roles, across more than 30 years.
Dr Batten is currently a non-executive director of Medibank Private Ltd (ASX listed), the Accident
Compensation Corporation (a NZ Crown insurance scheme and investment fund) and the National
Institute of Water and Atmospheric Research (a NZ Crown Research Institute). In addition, Dr Batten
was previously non-executive director of Abano Healthcare Group Ltd (NZX listed) and various other
healthcare related research institutes, charities and industry and government bodies.
During her senior executive career, Dr Batten was Group CEO of Imperial College Healthcare NHS
Trust in the United Kingdom, Group CEO of St Vincent’s Health Australia, CEO of Eastern Health, CEO
of Dental Health Services Victoria and held various other clinical and medical leadership roles.
Through her previous roles, Dr Batten brings experience in customer service, strategy, mergers &
acquisitions, risk management and corporate governance, as well as a demonstrated understanding
of working with regulators and governments in a healthcare context.
EBOS Chair Liz Coutts said “Tracey’s extensive healthcare sector expertise, as well as her non-
executive and senior executive experience at pre-eminent organisations, will be invaluable to EBOS.
We look forward to welcoming her to the Board.”
The Board has determined that Dr Batten will be an independent director (as defined in the NZX
Listing Rules). Dr Batten resides in New Zealand.
For further information please contact:
Martin Krauskopf
General Manager, Mergers & Acquisitions and Investor Relations
+61 3 9918 5555
Authorised for lodgement with NZX and ASX by Janelle Cain, General Counsel, EBOS Group Limited.
About EBOS Group
EBOS Group Limited NZBN 9429031998840 (NZX/ASX Code: EBO) is the largest and most diversified
Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical
products. It is also a leading Australasian animal care brand owner, product marketer and distributor.
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- GXH — Green Cross Health Limited: Green Cross Health Limited 2021 Annual Report2021-06-24
“Annual Report 2021 | 59 Peter Merton, Non-Executive Director Peter Merton, an Otago University Pharmacy graduate, has been involved in the pharmaceutical industry in New Zealand and overseas since the early 1980s. His involvement with the Group goes back to the late 1990s, and…”
- BGP — Briscoe Group Limited: Annual Shareholders Meeting2021-04-12
“Annual Report The Annual Report for the year ended 31 January 2021, and previous periods, are available at http://briscoegroup.co.nz/investor-centre/. Copies of all future reports will also be available for you to view on this webs…”
- BLT — BLIS Technologies Limited: e-Commere Director appointment to Executive Leadership Team2021-05-19
“20 May 2021 e-Commerce Director appointment to Executive Leadership Team Blis Technologies is pleased to announce the appointment of Laura Grant to the role of e-Commerce Director from 24 May 2021. Laura joins Blis Technologies from Lion where she was National Account Man…”